Coronary Obstruction Detection by Molecular Personalized Gene Expression (Corus CAD or ASGES)
Public ClinicalTrials.gov record NCT01117506. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Blood-based Gene Expression Test (Corus CAD or ASGES) for Obstructive Coronary Artery Disease Tested in Symptomatic Nondiabetic Patients Referred for Myocardial Perfusion Imaging.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To validate the use of Corus CAD (Age/Sex/Gene Expression score - ASGES) blood assay in subjects who are referred for the work-up of coronary artery disease. The study will evaluate the clinical utility of a gene expression test Corus CAD (Age, Sex, Gene Expression Score - ASGES) in subjects referred for myocardial perfusion imaging (MPI) work-up for suspected obstructive atherosclerotic coronary artery disease (CAD). The Corus CAD (ASGES) is a gene expression test that quantify the expression of multiple genes from circulating peripheral blood cells to detect the presence of clinically significant obstructive CAD in patients with chest pain.
Study identification
- NCT ID
- NCT01117506
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 581 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 35 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2010 (Type not available)
- Primary completion
- May 2011 (Actual)
- Completion
- May 2012 (Actual)
- Last update posted
- Jan 31, 2019
2010 – 2012
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Long Beach Memorial Hospital | Long Beach | California | 90806 | — |
| Sutter Roseville Medical Center | Roseville | California | 95661 | — |
| Pikes Peak Cardiology | Boulder | Colorado | 80909 | — |
| Midwest Cardiology Associates | Overland Park | Kansas | 66209 | — |
| St. Luke's Hospital | Kansas City | Missouri | 64111 | — |
| Berks Cardiologists, Ltd | Wyomissing | Pennsylvania | 19610 | — |
| Cardiovascular Associates of Virginia | Midlothian | Virginia | 23114 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01117506, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 31, 2019 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01117506 live on ClinicalTrials.gov.